Research Fellow
Research Institute For Scientists Emeriti (R.I.S.E) At Drew University
AeroLeads people directory · profile
Brian Mckittrick Email & Phone Number
Research Fellow
at
Research Institute for Scientists Emeriti (R.I.S.E) at Drew University
1 work email found
@spcorp.com
6 phones found area 908, 973, and 630
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Role
Research Fellow
Location
New Vernon, New Jersey, United States
Who is Brian Mckittrick? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Brian Mckittrick is listed as Research Fellow at Research Institute for Scientists Emeriti (R.I.S.E) at Drew University, based in New Vernon, New Jersey, United States. AeroLeads shows a work email signal at spcorp.com, phone signal with area code 908, 973, 630, and a matched LinkedIn profile for Brian Mckittrick.
Brian Mckittrick previously worked as Advisor at Olipass Corporation and Advisor at Olipass Corporation. Brian Mckittrick holds Postdoctoral Studies, Natural Product Synthesis And New Methodology from Cornell University.
Company email context
Email format at Research Institute for Scientists Emeriti (R.I.S.E) at Drew University
This section adds company-level context without repeating Brian Mckittrick's masked contact details.
{first}.{last}@spcorp.com
86% confidence
AeroLeads found 1 current-domain work email signal for Brian Mckittrick. Compare company email patterns before reaching out.
Profile bio
About Brian Mckittrick
Together with my colleagues at Merck and Schering-Plough, we contributed to 7 clinical candidates, 2 of which were approved by the FDA (Zetia and Victrelis). I am very proud of the work we did to develop a novel pharmacophore for inhibiting aspartyl proteases which we used to develop leads for BACE, HIV and Renin. The lead series in BACE ultimately led to the discovery of Verubecastat which advanced to phase 3 to test the amyloid mechanism of Alzheimer's disease. After I left Merck, the leads from the renin program also provided inhibitors of plasmepsin which are being developed for the treatment of malaria. In 2017 I joined OliPass, a Korean biotech company, developing drug candidates using the antisense modality with a novel platform of cell-penetrating peptide nucleic acids (OPNAs). The lead program targets Nav1.7 and has advanced to phase 2 human trials.In 2022, I moved into an advisory role at Olipass and I also joined the RISE program at Drew University. as a research fellow. I have set up my own lab doing early stage med chem projects working with Drew students and we are open to collaborations with biologists.
Listed skills include Drug Discovery, Drug Design, Medicinal Chemistry, Lead Change, and 14 others.
Current workplace
Brian Mckittrick's current company
Company context helps verify the profile and gives searchers a useful next step.
Research Institute For Scientists Emeriti (R.I.S.E) At Drew University
AeroLeads page
9 roles · 41 years
Brian Mckittrick work experience
A career timeline built from the work history available for this profile.
Advisor
Current
May 2022 - Present
Advisor
Current
Olipass Corporation
At OliPass we are advancing the next generation of antisense therapeutics based on our proprietary OPNA platform of cell penetrating peptide nucleic acids.
May 2019 - Present
Research Fellow
Current
Research Institute For Scientists Emeriti (R.I.S.E) At Drew University
Collaborative early stage med chem projects: 1) developing targeted protein degraders ( TPDs) using novel E3 ligases and 2) developing inhibitors of the taurine transporter to determine the effect of taurine on the development of resistance to chemotherapy treatment of ovarian cancer.
Jan 2022 - Present
Drug Discovery Consultant
Current
Pipeline Partner Llc
Pipeline Partner, LLC is a medicinal chemistry and drug discovery-focused consulting company providing experience and guidance with hit finding, lead identification, structure based optimization, target validation, medicinal chemistry, due diligence, intellectual property and related work.
Mar 2017 - Present
Vp Of Science And Strategy
Olipass Corp
Apr 2017 - Apr 2022
Director Of Exploratory Chemistry
Led an exploratory chemistry group which was focused on improving the way we do target and hit validation. This included the thorough triage and optimization of screening hits to provide high quality tool molecules to allow us to make rigorous go or no-go decisions on the projects. During this time, I continued to use structure-based drug design and.
Nov 2009 - Nov 2016
Director Of Medicinal Chemistry
1) 1986-1996: Lead identification and optimization focused on Cardiovascular and Central Nervous System targets. Highlights include being a co-inventor of Zetia, which was approved by the FDA in 2002 as a novel cholesterol-lowering agent. This was the first and only drug ever approved that blocks the NPC1L1 receptor and it became a multi-billion/year.
1986 - 2009
~23 yrs
Medicinal Chemist
Ayerst
Synthetic Chemist working on potential backups to the anti-inflammatory agent Etodolac.Developed novel chemistry for functionalization of the 7 position of highly substituted indoles.
1985 - 1986
~1 yr
4 education records
Brian Mckittrick education
Postdoctoral Studies, Natural Product Synthesis And New Methodology
Doctor Of Philosophy (Ph.D.), Organic Chemistry
Bs, Marine Science And Chemistry
Southampton College Of Liu
Doctor Of Philosophy - Phd, Organic Chemistry
FAQ
Frequently asked questions about Brian Mckittrick
Quick answers generated from the profile data available on this page.
What company does Brian Mckittrick work for?
Brian Mckittrick works for Research Institute for Scientists Emeriti (R.I.S.E) at Drew University.
What is Brian Mckittrick's role at Research Institute for Scientists Emeriti (R.I.S.E) at Drew University?
Brian Mckittrick is listed as Research Fellow at Research Institute for Scientists Emeriti (R.I.S.E) at Drew University.
What is Brian Mckittrick's email address?
AeroLeads has found 1 work email signal at @spcorp.com for Brian Mckittrick at Research Institute for Scientists Emeriti (R.I.S.E) at Drew University.
What is Brian Mckittrick's phone number?
AeroLeads has found 6 phone signal(s) with area code 908, 973, 630 for Brian Mckittrick at Research Institute for Scientists Emeriti (R.I.S.E) at Drew University.
Where is Brian Mckittrick based?
Brian Mckittrick is based in New Vernon, New Jersey, United States while working with Research Institute for Scientists Emeriti (R.I.S.E) at Drew University.
What companies has Brian Mckittrick worked for?
Brian Mckittrick has worked for Research Institute For Scientists Emeriti (R.I.S.E) At Drew University, Olipass Corporation, Pipeline Partner Llc, Olipass Corp, and Merck.
How can I contact Brian Mckittrick?
You can use AeroLeads to view verified contact signals for Brian Mckittrick at Research Institute for Scientists Emeriti (R.I.S.E) at Drew University, including work email, phone, and LinkedIn data when available.
What schools did Brian Mckittrick attend?
Brian Mckittrick holds Postdoctoral Studies, Natural Product Synthesis And New Methodology from Cornell University.
What skills is Brian Mckittrick known for?
Brian Mckittrick is listed with skills including Drug Discovery, Drug Design, Medicinal Chemistry, Lead Change, Drug Development, Chemistry, Parallel Synthesis, and Organic Chemistry.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trialPeople with similar names
Check these profiles if this is not the Brian Mckittrick you were looking for.
Brian McKittrick
2 email domains
Brian McKittrick
3 email domains
Brian McKittrick
1 email domain
Brian McKittrick
3 email domains